Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

144.04 +0.96 (+0.67%)
Streaming Delayed Price Updated: 1:45 PM EDT, May 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
CRL EQUITY ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CRL
From The Rosen Law Firm, P.A.
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Charles River Laboratories International, Inc. (CRL) Investors
From Law Offices of Howard G. Smith
Via Business Wire
Charles River: Q1 Earnings Insights
Via Benzinga
Will Chart Analysts Notice Bad Omen on Charles River's Chart
Via Benzinga
Analyst Ratings for Charles River
Via Benzinga
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Charles River Laboratories International, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
CRL CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Charles River Laboratories International, Inc.
From The Law Offices of Frank R. Cruz
Via Business Wire
CRL CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Charles River Laboratories International, Inc.
From Glancy Prongay & Murray LLP
Via Business Wire
3 DNA Stocks to Buy for the Synthetic Biology Revolution
Synthetic biology is a growing industry. The big winners will be DNA stocks that are able to sell to everyone, not just a small niche. 
Via InvestorPlace
Charles River Laboratories Announces First-Quarter 2023 Results
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID
From Charles River Laboratories International, Inc.
Via Business Wire
3 Healthcare Stocks With Huge Growth Potential
It's been a tough time for the tech industry. So consider these healthcare growth stocks to buy now instead. 
Via InvestorPlace
Bragar Eagel & Squire, P.C. Is Investigating Fox, Charles River, Provident, and Sarepta and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Charles River Laboratories Schedules First-Quarter 2023 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Laboratories Showcases End-to-End Oncology Capabilities at AACR 2023
From Charles River Laboratories International, Inc.
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Fox, FTX, RH, and Charles River and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Supply Chain
Exposures Legal Supply Chain
Charles River Laboratories International, Inc. (NYSE:CRL) Investor Alert: Investigation over Possible Violations of Securities Laws
San Diego, CA -- (SBWIRE) -- 03/13/2023 -- An investigation was announced for investors of Charles River Laboratories International, Inc. (NYSE:CRL) shares over potential securities laws violations by... 
Via SBWire
Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Laboratories to Present at Barclays Global Healthcare Conference
From Charles River Laboratories International, Inc.
Via Business Wire
ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Supply Chain
Exposures Legal Supply Chain
Charles River Launches Helper Plasmid to Streamline Adeno-Associated Viral Vector Manufacturing
From Charles River Laboratories International, Inc.
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Fox, Norfolk Southern, Charles River, and CCSI and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Supply Chain
Exposures Legal Supply Chain
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Supply Chain
Exposures Legal Supply Chain
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Charles River Laboratories International, Inc. (CRL) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
$39M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed lower on Friday, there were a few notable insider trades. 
Via Benzinga
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Charles River Laboratories International, Inc. Investors With Losses to Inquire About Securities Class Action Investigation - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Supply Chain
Exposures Legal Supply Chain
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Charles River Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.